"To contribute to a healthier world through innovation"
AB7 Group's mission is to contribute to a healthier world by improving the well-being of people and animals in their homes while having a positive social and environmental impact. We believe in the principle of "one health" and aim to become a player in this process. We aim to contribute to the current challenges by working with international partners to achieve this mission together. Innovation is at the heart of the solutions we propose to our customers and partners in the products and services we deliver.
The Group's DNA
We gravitate around five values that we consider essential, not to say vital. The DNA of the group, its activities and its commitments stem from them.
Having confidence in our human capital is our way of respecting our organisation and all our partners.
Innovate without limits, at all levels, to stay one step ahead.
Be agile to guarantee internal and external customer satisfaction.
Committing to act responsibly in line with our ambitions and the expectations of our customers.
Develop and integrate skills while promoting autonomy.
A family business on a human scale
AB7 is a Group majority owned by the founding family and managed today by its second generation.
The family business culture, reactive and flexible, remains anchored within the Group.
With its industrial know-how deployed in 2 units, in France and in the United States, AB7 is able to respond to specific manufacturing needs, from small series to large volumes, by offering the capacity to evolve and adapt.
A committed multidisciplinary team
We work with people who are proactive with regard to our partners' issues, but also with profiles that do not lack character in order to boost and grow projects on a daily basis. The integration of different formulation, analytical, entomology, microbiology, regulatory, quality and IP skills is a real strength for the group in its RDI activities.
Full service integration for global support and innovative turnkey products
Our scope of action can thus cover a very broad spectrum of expertise, both upstream and downstream of manufacturing, by intervening on the entire value chain: strategy, research, development, innovation, industrial transfer, quality, logistics and regulatory services, legal and industrial property.
Recognised expertise in health and care
AB7 is a leader in the development and manufacture of repellent and insecticide collars and pipettes. Its "drug delivery device" technology or delivery system for active pharmaceutical and non-pharmaceutical ingredients is its main differentiating factor. This adaptive technology is applicable to human, animal and environmental health and continues to offer innovative alternative solutions to more traditional galenic products.
Certifications
AB7 is an approved Veterinary Pharmaceutical Manufacturing Establishment.
AB7 America has been a Certified B Corp™ company since 2023.
AB7 is also a member of:
